The FDA recently authorized marketing of a new device designed to remove dead pancreatic tissue. ... The system should not be used in patients with known or suspected pancreatic cancer, and a boxed warning will emphasize this point, the FDA said.
The FDA suggests that clinicians should consider alternatives to eluxadoline in this population. ... Eluxadoline (Viberzi), a drug used to treat irritable bowel syndrome with diarrhea, should not be used in patients without gallbladders, the FDA warned
One lot of pantoprazole sodium for injection (40 mg per vial) was recalled from hospitals nationwide, the FDA announced on Dec.
On June 5, the FDA approved the first generic form of mesalamine delayed-release oral tablets USP (1.2 g).
On Feb. 7, the FDA cleared the updated design and labeling for the Pentax Medical Duodenoscope Model ED-3490TK. ... The FDA continues to monitor the association between reprocessed endoscopes and transmission of infectious agents.
The FDA has approved the oral antibacterial rifamycin (Aemcolo) to treat adults with travelers' diarrhea, the agency announced on Nov. ... 16. Compared to placebo, the drug significantly reduced symptoms in a randomized controlled trial of 264 adults
The FDA announced on Feb. 1 that it will add a new boxed warning to highlight the correct dosing for obeticholic acid (Ocaliva). ... In addition, a new medication guide required by the FDA will inform patients about the issue.
System 83 Plus automated endoscope reprocessors (AERs) by Custom Ultrasonics may now be used to process certain duodenoscopes, the FDA announced on April 10. ... The FDA determined that the data show that the AERs can achieve high-level disinfection of
To foster safer use of over-the-counter loperamide (Imodium), the FDA is implementing restrictions on its packaging. ... The FDA will continue to evaluate the drug's safety.
The FDA has permitted marketing of the Hemospray device to treat most types of upper or lower GI bleeding, the agency announced on May 7.